Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
Pozo-Rosich P, Dolezil D, Paemeleire K, Stepien A, Stude P, Snellman J, Arkuszewski M, Stites T, Ritter S, Lopez CL, Maca J, Ferraris M, Gil-Gouveia R.
Pozo-Rosich P, et al. Among authors: ritter s.
JAMA Neurol. 2024 Mar 25:e240368. doi: 10.1001/jamaneurol.2024.0368. Online ahead of print.
JAMA Neurol. 2024.
PMID: 38526461
Free PMC article.